CORRADO, ADDOLORATA
 Distribuzione geografica
Continente #
NA - Nord America 6.853
EU - Europa 5.133
AS - Asia 3.830
SA - Sud America 677
AF - Africa 52
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 16.566
Nazione #
US - Stati Uniti d'America 6.749
IE - Irlanda 1.575
CN - Cina 1.532
SG - Singapore 1.336
UA - Ucraina 1.005
SE - Svezia 746
BR - Brasile 566
RU - Federazione Russa 506
HK - Hong Kong 429
DE - Germania 269
IT - Italia 257
FR - Francia 194
FI - Finlandia 181
VN - Vietnam 166
GB - Regno Unito 119
TR - Turchia 114
CZ - Repubblica Ceca 96
IN - India 89
CA - Canada 58
AR - Argentina 43
AT - Austria 34
BD - Bangladesh 30
BE - Belgio 29
MX - Messico 29
PL - Polonia 29
EC - Ecuador 22
NL - Olanda 22
IQ - Iraq 20
ID - Indonesia 18
ZA - Sudafrica 17
JP - Giappone 16
LT - Lituania 12
ES - Italia 11
UZ - Uzbekistan 10
VE - Venezuela 10
IR - Iran 9
CL - Cile 8
DK - Danimarca 8
EU - Europa 8
PE - Perù 8
PY - Paraguay 8
CO - Colombia 7
EG - Egitto 7
MA - Marocco 7
SA - Arabia Saudita 7
NZ - Nuova Zelanda 6
PK - Pakistan 6
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
RO - Romania 5
AU - Australia 4
CH - Svizzera 4
JM - Giamaica 4
JO - Giordania 4
LB - Libano 4
PT - Portogallo 4
SN - Senegal 4
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
PA - Panama 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
KR - Corea 2
LU - Lussemburgo 2
LV - Lettonia 2
MN - Mongolia 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
CV - Capo Verde 1
DM - Dominica 1
DZ - Algeria 1
GE - Georgia 1
KH - Cambogia 1
LK - Sri Lanka 1
Totale 16.553
Città #
Dallas 1.814
Dublin 1.572
Chandler 713
Singapore 659
Jacksonville 657
Nyköping 500
Dearborn 455
Hong Kong 422
Beijing 367
Ashburn 327
Nanjing 300
Santa Clara 211
Princeton 163
Wilmington 157
Munich 132
Los Angeles 110
Moscow 100
Nanchang 94
San Mateo 90
The Dalles 89
Helsinki 86
New York 85
Brno 79
Ann Arbor 77
Boardman 77
Shenyang 73
Ho Chi Minh City 67
Des Moines 51
São Paulo 49
Tianjin 49
Hebei 46
Jiaxing 41
Guangzhou 39
Kunming 39
Shanghai 39
Foggia 37
Woodbridge 36
Changsha 35
Hanoi 34
London 31
Columbus 30
Chicago 28
Zhengzhou 27
Nuremberg 25
Brussels 24
Hangzhou 23
Brooklyn 22
Jinan 22
Assago 20
Xi'an 19
Seattle 18
Rio de Janeiro 17
San Francisco 17
Turku 17
Toronto 16
Lanzhou 15
Montreal 15
Norwalk 15
Boston 14
Falkenstein 14
Frankfurt am Main 14
Guayaquil 14
Milan 14
Bari 13
Ningbo 13
Olomouc 13
Vienna 13
Warsaw 13
Washington 13
Amsterdam 12
Hefei 12
Taizhou 12
Tokyo 12
Atlanta 11
Belo Horizonte 11
Hanover 11
Stockholm 11
Brasília 10
Noci 10
Pune 10
Rome 10
San Severo 10
Johannesburg 9
Paris 9
Phoenix 9
Salvador 9
Stevenage 9
Tashkent 9
Wuhan 9
Baghdad 8
Buffalo 8
Changchun 8
Curitiba 8
Klagenfurt 8
Kraków 8
Osasco 8
Council Bluffs 7
Da Nang 7
Houston 7
Mexico City 7
Totale 10.809
Nome #
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 483
1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis 448
Primary versus systemic sclerosis-associated Raynaud’s phenomenon: relationship with clinical and environmental factors 198
A case of rhupus treated with filgotinib: A promising therapeutic perspective 175
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 161
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 139
Extra-skeletal effects of bisphosphonates. 132
SUBSTANCE P AND VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS DERIVING FROM PATIENTS WITH SYSTEMIC SCLEROSIS 132
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 131
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 129
Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. 129
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 127
Adult Scheuermann's disease as cause of mechanic dorsalgia 126
Pubic symphysis sclerosis in psoriatic arthritis. Case report. 123
Two cases of distal extremity swelling with pitting oedema in psoriatic arthritis: the different pathological mechanisms. 122
How to Assess Pulmonary Circulation and Right Heart Chambers in Systemic Sclerosis Patients? 121
Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis 120
Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis 118
Corticosteroids, a review. 117
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. 116
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 114
COUNSELLING ON FAMILY PLANNING AND CONTRACEPTION, AND PREGNANCY OUTCOME IN WOMEN WITH RHEUMATIC DISEASES: A NATIONAL SURVEY OF 398 PATIENT-REPORTED QUESTIONNAIRES FROM 24 RHEUMATOLOGY CENTERS 113
Multiprofessional and intrahospital experience for diagnosis and treatment of pulmonary arterial hypertension 112
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis 110
Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept. 110
Extracellular Matrix modulates angiogenesis in physiological and pathological conditions 109
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease. 109
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 108
Bisphosphonates: effects on osteoblast. 108
Anti-TNF-α and risk of infections: the experience in one center. 108
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 105
TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. 105
Mitochondrial disease mimicking polymyositis: a case report 104
Combined effect of Neridronate and specific antibiotic therapy in a case of tuberculous spondylodiscitis 104
La coxalgia 104
Bone effects of biologic drugs in rheumatoid arthritis. 104
RANKL/OPG Ratio and DKK-1 Expression in Primary Osteoblastic Cultures from Osteoarthritic and Osteoporotic Subjects 104
Anomalies de la capillaroscopie périunguéale au cours de la fibrose pulmonaire associée à la sclérodermie systémique et au cours de la fibrose pulmonaire idiopathique 104
Role of altered osteoblastic expression of Dkk-1 in the pathogenesis of osteoarthritis and osteoporosis 103
Comments on Addolorata Corrado et al. review “Extra-skeletal effects of bisphosphonates” 103
Bisphosphonates and osteoarthritis 102
Systemic effects of Wnt signaling 101
Obesity and Chronic Inflammation: Implications for Rheumatoid Arthritis, Spondyloarthritis, and Ulcerative Colitis 100
IgA nephropathy in systemic lupus erythematosus. 100
Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report 100
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: A EUSTAR analysis 100
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 99
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 99
Anabolic therapy of induced osteoporosisin beta-thalassaemia major: case report and literature review 98
Integrine expression on human osteoblasts in osteoarthritis 98
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 96
Juvenile idiopathic arthritis: an update on clinical and therapeutic approaches 96
Metabolic effects of zoledronate on primary human osteoblastic cell cultures 96
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment 96
Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database 96
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 95
SERUM 25(OH) VITAMIN D LEVELS, BODY MASS COMPOSITION AND EXTENT OF SKIN SCLEROSIS IN SYSTEMIC SCLEROSIS PATIENTS 95
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases 95
Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 94
Osteoporosis and rheumatic diseases 93
Intestinal histological and ultrastructural inflammatory changes in spondyloarthropathy and rheumatoid arthritis. 93
Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis 93
AN EXEMPLAR BEHCET CASE, IN ALL ITS MULTISYSTEMIC FEATURES 93
AB0171 Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 93
Osteocytes: central conductors of bone biology in normal and pathological conditions 92
Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis 92
Osteoblast as a target of anti-osteoporotic treatment 92
Osteoblast physiology in normal and pathological conditions 91
Osteocalcin: Skeletal and extra-skeletal effects 91
Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts 91
Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms 91
Effects of Infliximab on human osteoblastic cells from rheumatoid arthrtis subjects 90
T cells support osteoclastogenesis in an in vitro model derived from human psoriatic arthritis 90
Bilateral sequential central retinal vein occlusion associated with primary antiphospholipid syndrome 90
Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis 90
ANTI-CARBAMYLATED PROTEIN ANTIBODIES IN PATIENTS WITH SYSTEMIC SCLEROSIS: AN INTRIGUING ASSOCIATION WITH SKIN INVOLVEMENT 90
Pathogenesis, clinical findings and management of acute and chronic gout. 90
Impact of Systematic Isolation of Superior Vena Cava in Addition to Pulmonary Vein Antrum Isolation on the Outcome of Paroxysmal, Persistent, and Permanent Atrial Fibrillation Ablation: Results from a Randomized Study 89
THU0145 Changes in bone metabolism and trabecular bone score in patients with early rheumatoid arthritis 89
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 89
INHIBITORY EFFECT OF 1,25OH VITAMIN D ON IL-17 RELATED PRO-FIBROTIC CYTOKINES EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 89
Membranous nephropathy in rheumatoid arthritis: a case report. 88
Osteoblast role in osteoarthritis pathogenesis 88
Successful treatment of avascular bone necrosis of the knee with neridronate: a case report 87
Combined effects of infliximab and methotrexate on rheumatoid arthritis osteoblastic cell metabolism 87
Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis 87
Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts. 86
Glucocorticoid induced risk of fractures 86
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud’s phenomenon: a case–control study 86
Adipokines and Chronic Rheumatic Diseases: from Inflammation to Bone Involvement 86
Glucocorticoid induced risk of fractures. 85
EFFECTS OF DIFFERENT ANTI TNF ALPHA TREATMENTS ON LIPID AND CARBOHYDRATE METABOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS 85
Effects of Infliximab on human osteoblastic cells from rheumatoid arthritis subjects 85
Janus kinase inhibitors role in bone remodeling 85
Cervical myelopathy caused by periodontoid synovial pannus in a patient with psoriatic arthritis: a case report. 84
Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension 84
FRI0468 EFFECTS OF DIFFERENT VITAMIN D SUPPLEMENTATION SCHEMES IN POSTMENOPAUSAL WOMEN 84
Neridronate and osteoporotic and ostearthitic human osteoblasts 83
Psoriatic arthritis and Klinefelter syndrome: case report. 82
Gotta 82
Totale 10.965
Categoria #
all - tutte 100.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.059


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021742 0 0 0 0 0 56 175 162 173 160 3 13
2021/2022840 99 13 9 9 65 18 28 72 134 125 34 234
2022/20233.674 325 162 171 154 189 326 20 306 1.791 30 95 105
2023/2024739 108 39 45 30 44 140 15 28 1 38 19 232
2024/20253.011 167 24 67 113 109 496 280 206 738 215 296 300
2025/20264.265 378 813 1.996 740 301 37 0 0 0 0 0 0
Totale 17.266